Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Benchling Announces Groundbreaking Workflow & Results Management Solution to Organize, Optimize, and Measure Biologics R&D

SAN FRANCISCO, Sept. 20, 2017 /PRNewswire/ -- Benchling, the next-generation biologics R&D software company, today announced the release of its Workflow & Results Management system, a new class of informatics software that organizes, optimizes, and measures experimental progress from... Read more ››

By: PR Newswire Association LLC. - 20 Sep 2017

e-Pharma Market Size Worth $109.2 Billion by 2025 | CAGR: 14.8%: Grand View Research, Inc.

SAN FRANCISCO, September 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Sep 2017

DelMar Pharmaceuticals Announces Issuance of New Patent on First-in-Class DNA-targeting Agent, VAL-083

VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 20, 2017 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the U.S. Patent and Trademark Office... Read more ››

By: PR Newswire Association LLC. - 20 Sep 2017

Soligenix Announces $1.5 Million NIDCR SBIR Grant Award Supporting the Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer

PRINCETON, N.J., Sept. 20, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the National Institute... Read more ››

By: PR Newswire Association LLC. - 20 Sep 2017
Related companies:  Soligenix, Inc.

Today's Research Report Coverage on Healthcare Stocks -- AMAG Pharma, IDEXX Laboratories, Palatin Technologies, and Bio-Path

NEW YORK, September 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Sep 2017
Related companies:  IDEXX Laboratories, Inc. | Palatin Technologies, Inc. | AMAG Pharmaceuticals, Inc. | Bio-Path Holdings, Inc.

Technical Reports on Biotech Equities -- Vanda Pharma, ACADIA Pharma, Achillion Pharma, and Agios Pharma

NEW YORK, September 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Sep 2017
Related companies:  ACADIA Pharmaceuticals Inc. | Vanda Pharmaceuticals | Achillion Pharmaceuticals, Inc. | Agios Pharmaceuticals, Inc.

Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

EDINBURGH, Scotland, September 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Sep 2017

Sebbin's Statement on Anaplastic Large Cell Lymphoma (ALCL) & Breast Implants

BOISSY L'AILLERIE, France, September 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Sep 2017

Syndax Pharmaceuticals Announces Updated Presentation Time at the Cantor Fitzgerald Global Healthcare Conference

WALTHAM, Mass., Sept. 20, 2017 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 in multiple cancer indications, today announced an update to the time of the Company's presentation at the Cantor Fitzgerald... Read more ››

By: PR Newswire Association LLC. - 20 Sep 2017
Related companies:  Syndax Pharmaceuticals, Inc.

Intec Pharma to Participate in the Ladenburg Thalmann 2017 Healthcare Conference

JERUSALEM, September 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Sep 2017

OTC Markets Group Welcomes Beleave to OTCQX

NEW YORK, Sept. 20, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000... Read more ››

By: PR Newswire Association LLC. - 20 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Global Medical Alert System/Personal Emergency Response System Market, 2023 - Thriving Healthcare Market to Create Need for Affordable Medical Alert Devices

DUBLIN, September 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy

SAN FRANCISCO, Sept. 20, 2017 /PRNewswire-USNewswire/ -- The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI) today... Read more ››

By: PR Newswire Association LLC. - 20 Sep 2017

Edesa Biotech Completes Financing to Develop Novel Dermatology and Anorectal Treatments

MARKHAM, ON, Sept. 20, 2017 /CNW/ - Edesa Biotech Inc., a clinical-stage private company announced today the completion of a $7 million Series A financing. The internationally syndicated investment was led by Lumira Capital and included participation from Pharmascience Inc., Inveready Technology... Read more ››

By: PR Newswire Association LLC. - 20 Sep 2017
Related companies:  Edesa Biotech Inc.

Sierra Oncology to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

- "Beyond PARP - Next Generation DDR Therapeutics" scheduled for 8:35 am ET on
September 26, 2017 -

Read more ››
By: PR Newswire Association LLC. - 20 Sep 2017
Related companies:  Sierra Oncology, Inc.

Bone Therapeutics SA : announces all patients meet primary endpoint in ALLOB® Phase I/IIA delayed-union study interim analysis

Read more ››
By: Nasdaq / GlobenewsWire - 20 Sep 2017
Related companies:  Bone Therapeutics S. A.

argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113 in immune thrombocytopenia

Read more ››
By: Nasdaq / GlobenewsWire - 20 Sep 2017
Related companies:  argenx SE

Novartis drug Rydapt® (midostaurin) receives EU approval for newly diagnosed FLT3-mutated acute myeloid leukemia (AML) and three types of advanced systemic mastocytosis (SM)

Read more ››
By: Nasdaq / GlobenewsWire - 20 Sep 2017
Related companies:  Novan Therapeutics

Shire and Shionogi Announce Positive Topline Results for INTUNIV® Evaluated in Phase 3 Clinical Trial in Adults with ADHD

Read more ››
By: Nasdaq / GlobenewsWire - 20 Sep 2017
Related companies:  ShangPharma Corp. (SHP)

Dr. Vaidya's Uses a 5,000 year-old Science to Solve 21st Century Problems With the Launch of HERBOfit and LIVitup

MUMBAI, September 20, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Sep 2017
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑